| Home » Drugs » |
|
WWW.FINZFIRM.COM
1-888-FINZFIRM
1-888-346-9347
New York Bextra Lawyer
Bextra is a non-steroidal anti-inflammatory drug used for the treatment of osteoarthritis, rheumatoid arthritis, and painful menstruation and menstrual symptoms. However, concerns about the medication's link to serious heart attacks and strokes led to the withdrawal of the drug from the market. Have you or a family member suffered from the serious side effects of Bextra? A New York lawyer can help you seek compensation for your injuries. Contact a New York Bextra Lawyer today!Serious Side Effects of Bextra
Manufactured and marketed under the brand name Bextra, the drug was available by prescription until 2005, when it was removed from the market due to concerns about the drug's serious side effects.Clinical studies have indicated that Bextra is associated with increased risk of heart attacks and strokes. Patients taking Bextra were also at risk for serious allergic reactions and anaphylactic shock, which could prove dangerous or fatal. Furthermore, Bextra has been known to cause Stevens Johnson Syndrome, a potentially fatal skin disease that can lead to severe and painful blistering of the skin. For more information about Stevens Johnson Syndrome, click here or contact our New York Bextra Lawyer.
In addition to these serious side effects, the more common side effects of Bextra use include:
- indigestion
- diarrhea
- nausea
- headaches
- bloody or discolored stools
- jaundice
- flu-like symptoms
- weight gain
- water retention,
- increased bleeding or bruising
Such studies and findings of these serious side effects have caused the FDA to declare that the dangers of Bextra use outweighs its potential benefits. Patients are urged to report the side effects and seek immediate medical attention should the need arise. After seeking medical attention, contact a New York Bextra Lawyer at Finz & Finz, P.C. for information on your legal rights to compensation in New York.
FDA Announces Request for the Discontinuation of Bextra
On April 7, 2005, the FDA issued the following alert:
"FDA has requested that Pfizer voluntarily withdraw Bextra from the United States market. Pfizer has agreed to suspend sales and marketing of Bextra in the United States, pending further discussion with the Agency. At this time, the Agency has concluded that the overall risk versus benefit profile of Bextra is unfavorable. This conclusion is based on the potential increased risk for serious cardiovascular (CV) adverse events, which appears to be a class effect of non-steroidal anti-inflammatory drugs (NSAIDs) (excluding aspirin), an increased risk of serious skin reactions (e.g., toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme) compared to other NSAIDs, and the fact that Bextra has not been shown to offer any unique advantages over the other available NSAIDs."The decision to remove Bextra from the market follows the removals of Vioxx and Celebrex, both of which are also arthritis pain medications known as COX2 Inhibitors, for similar health risks. Though Pfizer, the pharmaceutical makers of Bextra, continues to declare the safety of the defective drug, the link to heart attacks and strokes is continuously supported by the FDA's findings. The FDA also recently denied Pfizer's request that Bextra be approved for the treatment of migraine headaches.
Legal Help for Bextra Users
To facilitate the process and to further understand your rights, consult with a New York lawyer who is knowledgeable regarding the dangerous side effects of Bextra.
If you, a family member or friend have suffered a serious illness, injury, or medical condition due to the use of Bextra, please contact a New York Bextra Lawyer of Finz & Finz, P.C. today at (888) FINZ-FIRM to speak with an experienced defective drug lawyer now or fill out the Free Case Evaluation form on the right of this page.
>> Back to Top
Bextra News